Hitachi Medical Systems America (HMSA) has introduced new MRI software platform, Evolution 5, which includes around 40 new features.


To provide customers with improved sharpness and clarity, Evolution 5 was integrated with new image processing algorithm Vivid, new reconstruction task (NCC) that reduces redundant noise pickup and new optimized FSE sequence opFSE.

The new platform provides liver imaging with iron quantification and breast imaging with breast spectroscopy for therapy monitoring.

Other applications of the new platform include selective saturation for controlled MRA evaluation in the abdomen, diffusion with enhanced functional analysis including kurtosis imaging (DKI) and motion compensation with complete neuro suite All Around RADAR.

HMSA MR and CT business units general manager and vice-president Sheldon Schaffer said: "Evolution 5 represents one of the most significant software releases for our MR platforms.

"As we look to expand our services to major regional hospitals and national health systems, Evolution 5 offers diagnostic capabilities which will give these customers a new choice among high-performance MR imaging systems."

Evolution 5 is currently available on Echelon Oval 1.5T, and will be launched on firm’s other MRI products such as Oasis 1.2T Open High-Field and Trillium Oval 3T systems by the end of this year.

The company will exhibit the new platform at the Radiological Society of North America (RSNA) 2015 exhibition, which is being held from 29 November to 4 December.

Earlier this month, Hitachi Medical obtained approval from the US Food and Drug Adminsitration (FDA) for two new CT models of the Scenaria platform.

The new CT models, including Scenaria SE 64 and SE 128, were developed to facilitate the higher daily scanning volumes of busy CT facilities.

Image: Hitachi Medical has introduced new MRI software platform Evolution 5. Photo: courtesy of Stuart Miles /